Clinical translation of biomarkers for ZL-1211, an anti-CLDN18.2 antibody, in patients with advanced solid tumors from a phase I dose-escalation study Zhen Luo, Xiao Wang, Xuehuo Zeng,Jiaqing Yi, Tegan Burns, Herman Liu, Xinyu Zhang, Wenyu Liu,Karl Hsu, Hua GongCANCER RESEARCH（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
